Literature DB >> 17359357

The astrocytic response towards invasive meningiomas.

L Zeltner1, J Schittenhelm, M Mittelbronn, F Roser, M Tatagiba, C Mawrin, Y J Kim, A Bornemann.   

Abstract

meningiomas disrupt the pial-glial basement membrane. This membrane is closely attached to the subpial glial endfeet forming the glia limitans. The fate of subpial astrocytes during the course of brain invasion by meningiomas is not known. In the present study we immunolabelled sections of 35 brain-invasive meningiomas (14 meningothelial meningiomas WHO grade I, 11 atypical WHO grade II and 10 anaplastic WHO grade III) using anti-collagen IV to label basement membrane material, and antibodies against astrocytic markers CD44, SPARC (secreted protein, acidic and rich in cysteine) and glial fibrillary acidic protein (GFAP). Astrocytes were present at the tumour-brain interface of 14/14 WHO grade I meningiomas, 9/11 WHO grade II tumours and 9/10 WHO grade III tumours. The presence of astrocytes was associated with an intact basement membrane in 11/14 WHO grade I meningiomas (P < 0.01), 6/9 WHO grade II tumours, and 6/9 WHO grade III tumours. However, tumour embedded in deep brain parenchyma lacked both an astrocytic reaction and basement membrane material. In conclusion, astrocytes eventually disappear from the tumour-brain interface during the course of meningioma infiltration. This observation might indicate that the survival of subpial astrocytes is dependent on an intact pial-glial basement membrane.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17359357     DOI: 10.1111/j.1365-2990.2006.00792.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  6 in total

1.  Phenotypic heterogeneity and plasticity of isocortical and hippocampal astrocytes in the human brain.

Authors:  Alexander A Sosunov; Xiaoping Wu; Nadejda M Tsankova; Eileen Guilfoyle; Guy M McKhann; James E Goldman
Journal:  J Neurosci       Date:  2014-02-05       Impact factor: 6.167

2.  Immunohistochemical characterization of brain-invasive meningiomas.

Authors:  Thomas Backer-Grøndahl; Bjørnar H Moen; Magnus B Arnli; Kathrin Torseth; Sverre H Torp
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 3.  Brain-invasive meningiomas: molecular mechanisms and potential therapeutic options.

Authors:  Chaoying Qin; Meng Huang; Yimin Pan; Yuzhe Li; Wenyong Long; Qing Liu
Journal:  Brain Tumor Pathol       Date:  2021-04-26       Impact factor: 3.298

Review 4.  Brain invasion in meningiomas-clinical considerations and impact of neuropathological evaluation: a systematic review.

Authors:  Benjamin Brokinkel; Katharina Hess; Christian Mawrin
Journal:  Neuro Oncol       Date:  2017-10-01       Impact factor: 12.300

5.  CD13 is a useful tool in the differential diagnosis of meningiomas with potential biological and prognostic implications.

Authors:  Stefano Marletta; Claudio Luchini; Nicola Sperandio; Evelin Torresani; Alessandro Sorio; Ilaria Girolami; Aldo Scarpa; Albino Eccher; Claudio Ghimenton
Journal:  Virchows Arch       Date:  2022-02-25       Impact factor: 4.535

Review 6.  Updated Systematic Review on the Role of Brain Invasion in Intracranial Meningiomas: What, When, Why?

Authors:  Lara Brunasso; Lapo Bonosi; Roberta Costanzo; Felice Buscemi; Giuseppe Roberto Giammalva; Gianluca Ferini; Vito Valenti; Anna Viola; Giuseppe Emmanuele Umana; Rosa Maria Gerardi; Carmelo Lucio Sturiale; Alessio Albanese; Domenico Gerardo Iacopino; Rosario Maugeri
Journal:  Cancers (Basel)       Date:  2022-08-27       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.